Search alternatives:
significant side » significant sex (Expand Search), significant burden (Expand Search), significant source (Expand Search)
side decrease » sizes decrease (Expand Search), fid decreased (Expand Search), step decrease (Expand Search)
significant side » significant sex (Expand Search), significant burden (Expand Search), significant source (Expand Search)
side decrease » sizes decrease (Expand Search), fid decreased (Expand Search), step decrease (Expand Search)
-
81
Comparative Summary of Characteristics with Statistically Significant Differences between the Two Classes Identified.
Published 2025“…<p>Comparative Summary of Characteristics with Statistically Significant Differences between the Two Classes Identified.…”
-
82
-
83
The significant differences between the post-measurement and the follow-up measurement for the experimental group.
Published 2023“…<p>The significant differences between the post-measurement and the follow-up measurement for the experimental group.…”
-
84
The significant differences between the post-measurement and the follow-up measurement for the control group.
Published 2023“…<p>The significant differences between the post-measurement and the follow-up measurement for the control group.…”
-
85
Significant metabolic differences between mode of delivery (caesarean section or vaginal delivery).
Published 2021“…<p>Significant metabolic differences between mode of delivery (caesarean section or vaginal delivery).…”
-
86
-
87
-
88
Families with significant differences in abundance between the LFD and HFD groups. Metagenomics analysis.
Published 2019“…<p>Families with significant differences in abundance between the LFD and HFD groups. …”
-
89
Significant joint angle and moment differences between generic and subject-specific models.
Published 2022“…End of weight acceptance phase depicted as the blue line. Areas of significant difference, as determined by statistical parametric mapping (grey).…”
-
90
Significant activation and muscle force differences between generic and subject-specific models.
Published 2022“…End of weight acceptance phase depicted as the blue line. Areas of significant difference, as determined by statistical parametric mapping (grey).…”
-
91
-
92
-
93
-
94
Significant between-group differences on mean scores between resilient and ongoing vulnerable groups on explanatory variables.
Published 2022“…<p>Significant between-group differences on mean scores between resilient and ongoing vulnerable groups on explanatory variables.…”
-
95
-
96
Mean differences and the significance of the differences between left and right knee meniscal measurements in the lateral mid-sagittal view.
Published 2020“…<p>Mean differences and the significance of the differences between left and right knee meniscal measurements in the lateral mid-sagittal view.…”
-
97
Mean differences and the significance of the differences between the left and right knee meniscal measurements in the medial mid-sagittal view.
Published 2020“…<p>Mean differences and the significance of the differences between the left and right knee meniscal measurements in the medial mid-sagittal view.…”
-
98
Increasing TPP side chain length decreases melanoma cell viability and clonogenic survival.
Published 2020“…Results demonstrate that TPP derivatives decrease melanoma cell viability and clonogenic survival; and there is a structure-activity relationship between TPP side chain length and decreased viability and clonogenic survival.…”
-
99
Table1_Differences in kinetic factors affecting gait speed between lesion sides in patients with stroke.docx
Published 2024“…<p>The differences in kinetic mechanisms of decreased gait speed across brain lesion sides have not been elucidated, including the arrangement of motor modules reflected by kinetic interjoint coordination. …”
-
100
Significantly different normalized distributions between LTBI positive and negative patients.
Published 2025“…<p>Normalized conditions of TB1-NIL (A), TB1-MIT (B), and MIT-NIL (C) were significantly different between clinical populations of LTBI+ and LTBI− patients in some measured targets. …”